PublicationsThe U4 Blog

U4 Brief

Transparency and accountability in an electronic era: The case of pharmaceutical procurements

The burgeoning HIV/AIDS epidemic means that more labor and financial resources are being dedicated to the procurement of antiretroviral (ARV) medicines for reatment. While patients, physicians, national governments and development partners are eager to see treatment programs expanded, rapid scaleup often results in circumstances whereby resources have to be spent quickly, and sometimes resources are added to systems that are already weak and vulnerable to corruption. Program expansion in these circumstances can result in more risk, waste and losses, especially in the procurement process. Transparency of ARV prices is the first step towards identifying and minimizing corruption in procurement. This U4 Brief describes how international partners and national procurement agencies have used information technology to improve transparency and increase accountability in procurement of HIV/AIDS medicines.

4 May 2008
Read onlineDownload PDF
Transparency and accountability in an electronic era: The case of pharmaceutical procurements

Cite this publication


Waning, B. (2008) Transparency and accountability in an electronic era: The case of pharmaceutical procurements. Bergen: Chr. Michelsen Institute (U4 Brief 2008:10) 4 p.

Read onlineDownload PDF
Brenda Waning

Disclaimer


All views in this text are the author(s)’, and may differ from the U4 partner agencies’ policies.

This work is licenced under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND 4.0)

Photo